cancer
Dire shortages of two critical drugs — shortfalls that have threatened the lives and care of thousands of cancer patients — should be resolved within weeks, federal drug officials said.
The two drugs are doxorubicin and methotrexate, and in both cases supplies in the United States are being bolstered by shipments from abroad. Shortages of scores of other drugs continue.
“We’re not out of the woods,” said Dr. Sandra L. Kweder of the Food and Drug Administration’s drug center. “But these two particular shortages have been very, very upsetting to patients and to us.”
Read the full story: http://hcp.lv/y4wzkd
Source: The New York Times
GLP-1 Receptor Agonists Reduce Adverse Cardiovascular Outcomes, Improve Survival
August 2nd 2025Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Read More
5 Things Everyone Should Know for National Immunization Awareness Month
August 1st 2025National Immunization Awareness Month highlights the importance of lifelong vaccination to prevent diseases, a practice that has averted millions of deaths, proven to be a cost-effective public health strategy, and offers crucial protection even to individuals who are immunocompromised.
Read More